NEXT Financial Holdings’s Teva Pharmaceuticals TEVA Stock Holding History

NEXT Financial Holdings’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$14K	Buy	+882	New	+$15.6K	﹤0.01%	1045

Other funds holding TEVA

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

NEXT Financial Holdings's TEVA Position: Q1 2019 in Review

NEXT Financial Holdings opened a new position in Teva Pharmaceuticals (TEVA) in Q1 2019: 882 shares worth $14K. The stake represents ﹤0.01% of the portfolio and ranks #1045 among its holdings.

521 funds tracked by Wall St. Rank hold TEVA as of Q1 2019.

NEXT Financial Holdings held 882 shares of Teva Pharmaceuticals worth $14K as of Q1 2019.
Teva Pharmaceuticals was a new NEXT Financial Holdings position in Q1 2019.
Teva Pharmaceuticals made up ﹤0.01% of NEXT Financial Holdings's portfolio in Q1 2019, its #1045 holding.
521 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2019.

Based on NEXT Financial Holdings's 13F filing for Q1 2019, filed 13 May 2019.